Discover
SANA
Sana Biotechnology, Inc.
3.56
2 x 2.61
1 x 6.90
bid
ask
+
0.07
2.01%
2 @ 04:00 PM
3.52 -0.04 (1.12%)
| Ytd | -12.53% | |
| 1y | 21.92% |
3.44
day range
3.63
2.61
52 week range
6.55
| Open | 3.48 | Prev Close | 3.49 | Low | 3.44 | High | 3.63 | Mkt Cap | 990.72M |
| Vol | 2.88M | Avg Vol | 3.92M | EPS | -0.92 | P/E | N/A | Forward P/E | -5.28 |
| Beta | 1.96 | Short Ratio | 15.76 | Inst. Own | 78.15% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 3.21 | 200-d Avg | 3.85 | 1yr Est | 8.43 |
| Income Statement | |||
| Operating Expenses | 48.61M | ||
| Research and Development Expense | 37.15M | ||
| Selling, General and Administrative Expense | 11.46M | ||
| Operating Income | -48.61M | ||
| Net Income | -47.21M | ||
| Net Income Common Stock | -47.21M | ||
| Net Income Common Stock (USD) | -47.21M | ||
| Consolidated Income | -47.21M | ||
| Earnings per Basic Share | -0.17 | ||
| Earnings per Basic Share (USD) | -0.17 | ||
| Earnings per Diluted Share | -0.17 | ||
| Earning Before Interest & Taxes (EBIT) | -47.21M | ||
| Earning Before Interest & Taxes (USD) | -47.21M | ||
| Weighted Average Shares | 276.86M | ||
| Weighted Average Shares Diluted | 276.86M | ||
| Balance Sheet | |||
| Cash and Equivalents | 88.00M | ||
| Cash and Equivalents (USD) | 88.00M | ||
| Investments | 17.34M | ||
| Investments Current | 17.34M | ||
| Current Assets | 111.69M | ||
| Property, Plant & Equipment Net | 61.52M | ||
| Total Assets | 373.59M | ||
| Debt Current | 14.88M | ||
| Total Debt | 75.33M | ||
| Current Liabilities | 86.27M | ||
| Debt Non-Current | 60.45M | ||
| Total Liabilities | 254.35M | ||
| Accumulated Retained Earnings (Deficit) | -1.90B | ||
| Accumulated Other Comprehensive Income | -2.00K | ||
| Shareholders Equity | 119.24M | ||
| Shareholders Equity (USD) | 119.24M | ||
| Assets Non-Current | 261.90M | ||
| Total Debt (USD) | 75.33M | ||
| Goodwill and Intangible Assets | 199.82M | ||
| Liabilities Non-Current | 168.09M | ||
| Trade and Non-Trade Payables | 2.12M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.86M | ||
| Net Cash Flow from Financing | -128.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 11.93M | ||
| Capital Expenditure | -40.00K | ||
| Issuance (Purchase) of Equity Shares | -37.00K | ||
| Issuance (Repayment) of Debt Securities | -91.00K | ||
| Net Cash Flow from Investing | 49.44M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 49.48M | ||
| Net Cash Flow from Operations | -37.38M | ||
| Share Based Compensation | 5.66M | ||